FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to psychiatry, clinical psychopharmacology and psychopharmacotherapy. What is presented is the use of anxiolytic amide N-(6-phenylhexanoyl) glycyl-L-tryptophan, a dipeptide analogue of cholecystokinin (GB-115) as an agent possessing anxiolytic properties with an activating component.
EFFECT: preparation is characterized by good tolerance, without causing undesirable by-effects typical for anxiolytic agents with sedative action and preparations with psychostimulating activity.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THERAPEUTIC EFFICACY OF APHOBAZOLUM ANXIOLYTIC IN PATIENTS WITH ANXIETY DISORDERS | 2019 |
|
RU2736391C1 |
| USE OF METHYL ETHER OF N-CAPROYL-L-PROLYL-L-TYROSINE (DILEPT) AS AGENT WITH PSYCHOSTIMULANT ACTIVITY | 2015 |
|
RU2593886C1 |
| METHOD FOR PREDICTION OF EFFICACY OF LADASTEN THERAPY OF ORGANIC ASTHENIC DISORDERS | 2011 |
|
RU2459208C1 |
| METHOD OF DIAGNOSING AFFECTIVE DISORDERS IN PATIENTS WITH IHD BY DATA OF ENCEPHALOGRAPHIC EXAMINATION | 2009 |
|
RU2419383C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF PANIC DISORDER AND ORGANIC ANXIOUS DISORDER IN CONNECTION WITH VASCULAR DISEASE OF THE BRAIN | 2021 |
|
RU2770734C1 |
| METHOD FOR MONITORING REMOTE REHABILITATION PERIOD AFTERCARE AFTER TRANSURETHRAL PROSTATE RESECTION AND CLASSIC ADENECTOMY IN THE CASES OF INSUFFICIENT SATISFACTION WITH OPERATION RESULTS | 2001 |
|
RU2242230C2 |
| ANTI-ALCOHOL TEA FROM MEDICATIVE HERBS | 2003 |
|
RU2254137C1 |
| METHOD FOR CORRECTION OF PSYCHOSOMATIC DISEASES IN PATIENTS WITH IRRITATED BOWEL SYNDROME | 2017 |
|
RU2637628C1 |
| METHOD OF REHABILITATION OF PATIENTS WITH ALCOHOLISM | 2009 |
|
RU2436573C2 |
| SEDATIVE AND MUSCLE RELAXANT ACTION DRUG | 2019 |
|
RU2719376C1 |
